STOCK TITAN

Kura Oncology officer proposes $66.8K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Kura Oncology, Inc. (KURA) officer Teresa Bair gave notice of a proposed sale of 8,601 common shares, with an approximate sale date of November 16, 2026 and an aggregate market value of $66,829.77. She acquired the shares from the issuer on November 13, 2026 as a PSU. The past-three-month sales table lists 8,442 performance-based restricted stock units sold September 28 in a sell-to-cover transaction for $88,618.21 in gross proceeds, and 31,487 restricted stock units in an August 19 entry labeled 10b5-1 Sales, with $397,829.73 in gross proceeds.

Proposed shares for sale 8,601 shares Approximate sale date November 16, 2026
Aggregate market value $66,829.77 Proposed common-share sale
Shares outstanding 92,784,785 shares Reported in the securities information section
Performance-based restricted stock units sold 8,442 shares September 28 sale; sell-to-cover transaction
Gross proceeds $88,618.21 September 28 sell-to-cover transaction
Restricted stock units sold 31,487 shares August 19 entry labeled 10b5-1 Sales
Gross proceeds $397,829.73 August 19 entry labeled 10b5-1 Sales
sell-to-cover financial
"Sell-to-cover for Teresa Bair"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
Performance-Based Restricted Stock Units financial
"Performance-Based Restricted Stock Units sold"
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
10b5-1 Sales regulatory
"10b5-1 Sales for Teresa Bair"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KURA shares did Teresa Bair propose to sell?

Teresa Bair, an officer of Kura Oncology, Inc., reported a proposed sale of 8,601 common shares, with an approximate sale date of November 16, 2026 and an aggregate market value of $66,829.77.

What past-three-month KURA sales did Teresa Bair report?

The sales table lists 8,442 performance-based restricted stock units sold September 28 in a sell-to-cover transaction, with $88,618.21 in gross proceeds. It also lists 31,487 restricted stock units in an August 19 entry labeled 10b5-1 Sales, with $397,829.73 in gross proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading